We are happy to announce that Hubro Bioscience today has acquired the frameshift technology, products and titles of the now dissolved company Hubro Therapeutics AS. The acquisition was made by an agreement between Hubro Bioscience and the administrator of the Hubro Therapeutics AS bankruptcy estate. Hubro Bioscience will pursue developing the technology for cancer prevention.
